Corona Remedies shares list at 38% premium, Wakefit Innovations debuts flat

Corona Remedies' ₹655-crore IPO made a strong market debut on Monday and listed at 38.42% premium over the IPO price. Its shares, with a price band of ₹1,008-1,062 per share, were listed at ₹1,470 on the NSE and ₹1,452 on the BSE. While Wakefit Innovations' ₹1,289-crore IPO listed on NSE at ₹195, marking a flat listing over their IPO price.